8-K - Madrigal Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On January 29, 2026 (the “Effective Date”), Madrigal Pharmaceuticals, Inc. (the “Company”), F. Hoffmann-La Roche Ltd

Material Agreement

Source Document

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1* First Amendment to the Research, Development, and Commercialization Agreement,

Exhibits Only

Exhibits (2)

10.1

EXHIBIT 10.1

8-K

FORM 8-K